<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34970914</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2047-9980</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>04</Day></PubDate></JournalIssue><Title>Journal of the American Heart Association</Title><ISOAbbreviation>J Am Heart Assoc</ISOAbbreviation></Journal><ArticleTitle>Relationship Between Myocardial Injury During Index Hospitalization for SARS-CoV-2 Infection and Longer-Term Outcomes.</ArticleTitle><Pagination><StartPage>e022010</StartPage><MedlinePgn>e022010</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e022010</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1161/JAHA.121.022010</ELocationID><Abstract><AbstractText>Background Myocardial injury in patients with COVID-19 is associated with increased mortality during index hospitalization; however, the relationship to long-term sequelae of SARS-CoV-2 is unknown. This study assessed the relationship between myocardial injury (high-sensitivity cardiac troponin T level) during index hospitalization for COVID-19 and longer-term outcomes. Methods and Results This is a prospective cohort of patients who were hospitalized at a single center between March and May 2020 with SARS-CoV-2. Cardiac biomarkers were systematically collected. Outcomes were adjudicated and stratified on the basis of myocardial injury. The study cohort includes 483 patients who had high-sensitivity cardiac troponin T data during their index hospitalization. During index hospitalization, 91 (18.8%) died, 70 (14.4%) had thrombotic complications, and 126 (25.6%) had cardiovascular complications. By 12&#xa0;months, 107 (22.2%) died. During index hospitalization, 301 (62.3%) had cardiac injury (high-sensitivity cardiac troponin T&#x2267;14&#xa0;ng/L); these patients had 28.6%, 32.2%, and 33.2% mortality during index hospitalization, at 6 months, and at 12&#xa0;months, respectively, compared with 4.1%, 4.9%, and 4.9% mortality for those with low-level positive troponin and 0%, 0%, and 0% for those with undetectable troponin. Of 392 (81.2%) patients who survived the index hospitalization, 94 (24%) had at least 1 readmission within 12&#xa0;months, of whom 61 (65%) had myocardial injury during the index hospitalization. Of 377 (96%) patients who were alive and had follow-up after the index hospitalization, 211 (56%) patients had a documented, detailed clinical assessment at 6&#xa0;months. A total of 78 of 211 (37.0%) had ongoing COVID-19-related symptoms; 34 of 211 (16.1%) had neurocognitive decline, 8 of 211 (3.8%) had increased supplemental oxygen requirements, and 42 of 211 (19.9%) had worsening functional status. Conclusions Myocardial injury during index hospitalization for COVID-19 was associated with increased mortality and may predict who are more likely to have postacute sequelae of COVID-19. Among patients who survived their index hospitalization, the incremental mortality through 12&#xa0;months was low, even among troponin-positive patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Brittany</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-0177-2091</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine Department of Medicine, Heart and Vascular Center Brigham and Women's Hospital Harvard Medical School Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siddiqi</LastName><ForeName>Hasan</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-2274-9405</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine Department of Medicine, Heart and Vascular Center Brigham and Women's Hospital Harvard Medical School Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Guohai</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-8826-403X</Identifier><AffiliationInfo><Affiliation>Center for Clinical InvestigationBrigham and Women's Hospital Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieira</LastName><ForeName>Jefferson</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5982-8847</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine Department of Medicine, Heart and Vascular Center Brigham and Women's Hospital Harvard Medical School Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Andy</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6551-2881</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Brigham and Women's Hospital Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rutherford</LastName><ForeName>Henry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Brigham and Women's Hospital Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitre</LastName><ForeName>Xhoi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Brigham and Women's Hospital Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feeley</LastName><ForeName>Monica</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6498-4403</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Brigham and Women's Hospital Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oganezova</LastName><ForeName>Karina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Brigham and Women's Hospital Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varshney</LastName><ForeName>Anubodh S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0002-9697-8948</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine Department of Medicine, Heart and Vascular Center Brigham and Women's Hospital Harvard Medical School Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatt</LastName><ForeName>Ankeet S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine Department of Medicine, Heart and Vascular Center Brigham and Women's Hospital Harvard Medical School Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nauffal</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine Department of Medicine, Heart and Vascular Center Brigham and Women's Hospital Harvard Medical School Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atri</LastName><ForeName>Deepak S</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0001-8139-5419</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine Department of Medicine, Heart and Vascular Center Brigham and Women's Hospital Harvard Medical School Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blankstein</LastName><ForeName>Ron</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine Department of Medicine, Heart and Vascular Center Brigham and Women's Hospital Harvard Medical School Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlson</LastName><ForeName>Elizabeth W</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Inflammation, and Immunity Brigham and Women's Hospital Harvard Medical School Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Carli</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3119-025X</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine Department of Medicine, Heart and Vascular Center Brigham and Women's Hospital Harvard Medical School Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baden</LastName><ForeName>Lindsey R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Brigham and Women's Hospital Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatt</LastName><ForeName>Deepak L</ForeName><Initials>DL</Initials><Identifier Source="ORCID">0000-0002-1278-6245</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine Department of Medicine, Heart and Vascular Center Brigham and Women's Hospital Harvard Medical School Boston MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woolley</LastName><ForeName>Ann E</ForeName><Initials>AE</Initials><Identifier Source="ORCID">0000-0002-2810-1618</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Brigham and Women's Hospital Boston MA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL159276</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL094301</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Heart Assoc</MedlineTA><NlmUniqueID>101580524</NlmUniqueID><ISSNLinking>2047-9980</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020107">Troponin T</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006335" MajorTopicYN="Y">Heart Injuries</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020107" MajorTopicYN="N">Troponin T</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword><Keyword MajorTopicYN="N">troponin T</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>31</Day><Hour>8</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34970914</ArticleId><ArticleId IdType="pmc">PMC9075193</ArticleId><ArticleId IdType="doi">10.1161/JAHA.121.022010</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M. Characteristics and outcomes of 21 critically Ill patients with COVID&#x2010;19 in Washington State. JAMA. 2020;323:1612&#x2013;1614. doi: 10.1001/jama.2020.4326</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.4326</ArticleId><ArticleId IdType="pmc">PMC7082763</ArticleId><ArticleId IdType="pubmed">32191259</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID&#x2010;19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846&#x2013;848. doi: 10.1007/s00134-020-05991-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05991-x</ArticleId><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID&#x2010;19). JAMA Cardiol. 2020;5:811&#x2013;818. doi: 10.1001/jamacardio.2020.1017</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID&#x2010;19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu BO, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus&#x2010;infected pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi HK, Weber B, Zhou G, Regan J, Fajnzylber J, Coxen K, Corry H, Yu XG, DiCarli M, Li JZ, et al. Increased prevalence of myocardial injury in patients with SARS&#x2010;CoV&#x2010;2 viremia. Am J Med. 2020;134:542&#x2013;546. doi: 10.1016/j.amjmed.2020.09.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2020.09.046</ArticleId><ArticleId IdType="pmc">PMC7654293</ArticleId><ArticleId IdType="pubmed">33181107</ArticleId></ArticleIdList></Reference><Reference><Citation>Bavishi C, Bonow RO, Trivedi V, Abbott JD, Messerli FH, Bhatt DL. Special article &#x2010; acute myocardial injury in patients hospitalized with COVID&#x2010;19 infection: a review. Prog Cardiovasc Dis. 2020;63:682&#x2013;689. doi: 10.1016/j.pcad.2020.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7274977</ArticleId><ArticleId IdType="pubmed">32512122</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi HK, Libby P, Ridker PM. COVID&#x2010;19 &#x2013; a vascular disease. Trends Cardiovasc Med. 2021;31:1&#x2013;5. doi: 10.1016/j.tcm.2020.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7556303</ArticleId><ArticleId IdType="pubmed">33068723</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval Y, Januzzi JL, Jaffe AS. Cardiac troponin for assessment of myocardial injury in COVID&#x2010;19: JACC review topic of the week. J Am Coll Cardiol. 2020;76:1244&#x2013;1258. doi: 10.1016/j.jacc.2020.06.068</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.068</ArticleId><ArticleId IdType="pmc">PMC7833921</ArticleId><ArticleId IdType="pubmed">32652195</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP, STROBE Initiative . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573&#x2013;577. doi: 10.7326/0003-4819-147-8-200710160-00010</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-147-8-200710160-00010</ArticleId><ArticleId IdType="pubmed">17938396</ArticleId></ArticleIdList></Reference><Reference><Citation>Sesso HD, Paffenbarger RS, Lee I&#x2010;M. Comparison of national death index and world wide web death searches. Am J Epidemiol. 2000;152:107&#x2013;111. doi: 10.1093/aje/152.2.107</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/152.2.107</ArticleId><ArticleId IdType="pubmed">10909946</ArticleId></ArticleIdList></Reference><Reference><Citation>
COVIDProtocols: Patient Assessment
. COVIDProtocols. https://60550a9745c1270007339766&#x2010;&#x2010;covid&#x2010;protocols&#x2010;web.netlify.app/en/addendum/ward&#x2010;design&#x2010;troubleshooting/ Accessed March 23, 2021.</Citation></Reference><Reference><Citation>Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high&#x2010;sensitivity cardiac troponin T assay. Clin Chem. 2010;56:254&#x2013;261. doi: 10.1373/clinchem.2009.132654</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2009.132654</ArticleId><ArticleId IdType="pubmed">19959623</ArticleId></ArticleIdList></Reference><Reference><Citation>deFilippi CR, de Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, Zhan M, Seliger SL. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA. 2010;304:2494. doi: 10.1001/jama.2010.1708</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.1708</ArticleId><ArticleId IdType="pmc">PMC3559101</ArticleId><ArticleId IdType="pubmed">21078811</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, et al. Post&#x2010;acute COVID&#x2010;19 syndrome. Nat Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, Mangsbo SM, Nilsson P, Hober S, Th&#xe5;lin C. Symptoms and functional impairment assessed 8 months after mild COVID&#x2010;19 among health care workers. JAMA. 2021;325:2015&#x2013;2016. doi: 10.1001/jama.2021.5612</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner AM, Robinson DA, Yang L, Williams CF, Newman LM, Breen JJ, Eisinger RW, Schneider JS, Adimora AA, Erbelding EJ. Toward understanding COVID&#x2010;19 recovery: National Institutes of Health workshop on postacute COVID&#x2010;19. Ann Intern Med. 2021;174:999&#x2013;1003. doi: 10.7326/M21-1043</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-1043</ArticleId><ArticleId IdType="pmc">PMC8025940</ArticleId><ArticleId IdType="pubmed">33780290</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995;57:289&#x2013;300.</Citation></Reference><Reference><Citation>Writing Committee for the COMEBAC Study Group , Morin L, Savale L, Pham T, Colle R, Figueiredo S, Harrois A, Gasnier M, Lecoq A&#x2010;L, Meyrignac O, Noel N, et al. Four&#x2010;month clinical status of a cohort of patients after hospitalization for COVID&#x2010;19. JAMA. 2021;325:1525&#x2013;1534. doi: 10.1001/jama.2021.3331</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, Chu HY. Sequelae in adults at 6 months after COVID&#x2010;19 infection. JAMA Netw Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo LI, Liu M, Zhou X, et al. 6&#x2010;Month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee J, Canamar CP, Voyageur C, Tangpraphaphorn S, Lemus A, Coffey C, Wald&#x2010;Dickler N, Holtom P, Shoenberger J, Bowdish M, et al. Mortality and readmission rates among patients with COVID&#x2010;19 after discharge from acute care setting with supplemental oxygen. JAMA Netw Open. 2021;4:e213990. doi: 10.1001/jamanetworkopen.2021.3990</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.3990</ArticleId><ArticleId IdType="pmc">PMC8017465</ArticleId><ArticleId IdType="pubmed">33792728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, Banerjee A. Post&#x2010;covid syndrome in individuals admitted to hospital with covid&#x2010;19: retrospective cohort study. BMJ. 2021;372:n693. doi: 10.1136/bmj.n693</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>The RECOVERY Collaborative Group , Horby, P , Lim, WS , et al. Dexamethasone in hospitalized patients with Covid&#x2010;19. N Engl J Med. 2021;384:693&#x2013;704. doi: 10.1056/NEJMoa2021436</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>McEvoy JW, Chen Y, Ndumele CE, Solomon SD, Nambi V, Ballantyne CM, Blumenthal RS, Coresh J, Selvin E. 6&#x2010;Year change in high sensitivity cardiac troponin&#x2010;T and risk for subsequent coronary heart disease, heart failure, and death. JAMA Cardiol. 2016;1:519&#x2013;528. doi: 10.1001/jamacardio.2016.0765</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2016.0765</ArticleId><ArticleId IdType="pmc">PMC5084093</ArticleId><ArticleId IdType="pubmed">27439107</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X, Sun W, Hoogeveen RC, Nambi V, Matsushita K, Folsom AR, Heiss G, Couper DJ, Solomon SD, Boerwinkle E, et al. High&#x2010;sensitivity troponin I and incident coronary events, stroke, heart failure hospitalization, and mortality in the ARIC study. Circulation. 2019;139:2642&#x2013;2653. doi: 10.1161/CIRCULATIONAHA.118.038772</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.038772</ArticleId><ArticleId IdType="pmc">PMC6546524</ArticleId><ArticleId IdType="pubmed">31030544</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao C, Wang Y, Gu X, Shen X, Zhou D, Zhou S, Huang J, Cao B, Guo Q, Network for the C&#x2010;AP . Association between cardiac injury and mortality in hospitalized patients infected with avian influenza A (H7N9) virus. Crit Care Med. 2020;48:451&#x2013;458. doi: 10.1097/CCM.0000000000004207</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004207</ArticleId><ArticleId IdType="pmc">PMC7098447</ArticleId><ArticleId IdType="pubmed">32205590</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, Shchendrygina A, Escher F, Vasa&#x2010;Nicotera M, Zeiher AM, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID&#x2010;19). JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>